Atovaquone-proguanil 250-100 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FJH0A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,644
Award facts
- Contract value 100% obligated
- $45,644.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $45,644.44 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 tablets) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical test kits across multiple therapeutic domains. The current delivery order for Atovaquone-Proguanil, an antimalarial medication commonly used for malaria prevention and treatment in military personnel deployed to endemic regions, reflects the company's role in fulfilling essential pharmaceutical needs for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJH0A?
SPE2DR26FJH0A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FJH0A worth?
The government has obligated $45,644 on SPE2DR26FJH0A.
Is contract SPE2DR26FJH0A an order under another contract?
Yes. SPE2DR26FJH0A is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH0A competed?
The extent of competition for SPE2DR26FJH0A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award